Clinical Trial Update: A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities [Phase 2]

View source ↗

Summary

A Phase 2 study of weekly oral Ecnoglutide (VRB-101) in adults with obesity or overweight with weight-related comorbidities is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Ecnoglutide (VRB-101) (ecnoglutide)

Snippet

Sponsor: Verdiva Bio Dev Limited | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING